INTECH Investment Management’s Fulcrum Therapeutics FULC Stock Holding History

INTECH Investment Management’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.2K	Buy	16,182 +2,940	+22%	+$17.9K	﹤0.01%	2035
2026 Q1	$102K	Sell	13,242 -6,505	-33%	-$60.3K	﹤0.01%	1890
2025 Q4	$223K	Buy	19,747 +2,503	+15%	+$25.5K	﹤0.01%	1925
2025 Q3	$159K	Sell	17,244 -10,814	-39%	-$78.2K	﹤0.01%	2145
2025 Q2	$193K	Sell	28,058 -17,631	-39%	-$94.3K	﹤0.01%	2106
2025 Q1	$132K	Buy	45,689 +15,190	+50%	+$55.8K	﹤0.01%	2241
2024 Q4	$143K	Buy	30,499 +13,057	+75%	+$48.2K	﹤0.01%	2129
2024 Q3	$62.3K	Buy	+17,442	New	+$129K	﹤0.01%	1961

Other funds holding FULC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

INTECH Investment Management's FULC Position: Q2 2026 in Review

INTECH Investment Management increased its Fulcrum Therapeutics (FULC) stake by 22% in Q2 2026, buying an estimated $17.9K and bringing the position to 16,182 shares worth $59.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2035.

INTECH Investment Management first reported a position in FULC in Q3 2024 and has held it in 8 quarters since. The position peaked at $223K in Q4 2025. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

INTECH Investment Management held 16,182 shares of Fulcrum Therapeutics worth $59.2K as of Q2 2026.
INTECH Investment Management bought 2,940 Fulcrum Therapeutics shares in Q2 2026, an estimated $17.9K.
Fulcrum Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2035 holding.
INTECH Investment Management first reported a position in Fulcrum Therapeutics in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Fulcrum Therapeutics position peaked at $223K in Q4 2025.
155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.